---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-026348"
form_type: "8-K"
ticker: "PMHS"
cik: "0001265521"
company_name: "Polomar Health Services, Inc."
filed_at: "2024-07-05T23:59:59+00:00"
generated_at: "2026-05-31T23:17:36.574576+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Trustfeed Corp. licenses patent-pending IP from affiliate Pinata Holdings for drug delivery products

## Summary
- Royalty rates: 10% for metformin, 15% for sumatriptan/sildenafil, 20% for semaglutide/liraglutide on net sales.
- License is worldwide, non-exclusive, perpetual; termination for material breach or 180 days notice.
- Intended use is in products after planned acquisition of Polomar Specialty Pharmacy, announced June 28, 2024.
- Pinata Holdings is an affiliate of CWR 1, LLC, the company's majority shareholder (related party transaction).
- License covers patent-pending IP and know-how for delivery of five active ingredients (metformin, sumatriptan, semaglutide, liraglutide, sildenafil).

## SEC filing metadata
- accession: 0001493152-24-026348
- form_type: 8-K
- ticker: PMHS
- cik: 0001265521
- company_name: Polomar Health Services, Inc.
- filed_at: 2024-07-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1265521/000149315224026348/0001493152-24-026348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1265521/000149315224026348/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-026348
- JSON: https://secwatch.observer/filing/0001493152-24-026348.json
- Plain text: https://secwatch.observer/filing/0001493152-24-026348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.